Add BrightSurf on Google Email

Breast cancer treatment reduces risk of heart disease

Tamoxifen has been shown to reduce breast cancer recurrence by up to 50% and lower heart disease risk in women with breast cancer. The study found that current use of tamoxifen was associated with a significantly reduced risk of heart disease, particularly in women who had completed less than two years of therapy.

SourceWiley·JournalCancer·DateFeb 14, 2005

New medication dramatically decreases congestive heart failure in African-American patients

African-American Heart Failure Trial (A-HeFT) reveals a 43% decrease in one-year mortality rates among patients taking the combined treatment, and significant improvements in overall survival and quality of life. The study suggests that BiDil can slow heart failure progression and reduce death rates in this population.

SourceUT Southwestern Medical Center·JournalNew England Journal of Medicine·DateNov 8, 2004

Protein not only aids nerve development, but promotes blood vessel growth, too

Researchers discovered that Netrin-1 stimulates cell proliferation, migration, and adhesion in endothelial cells and vascular smooth muscle cells, promoting angiogenesis. This finding has implications for treating diseases such as cancer and ischemic heart disease by either inhibiting or inducing blood vessel growth.

SourceUniversity of Utah Health·JournalProceedings of the National Academy of Sciences·DateNov 1, 2004

Ephedrine and unheralded sudden cardiac death

A new study by the American Medical Association links ephedrine to unheralded sudden cardiac death in individuals with asymptomatic heart disease. The study found that ephedrine can cause a potentially lethal arrhythmia when combined with a heart blockage, increasing the risk of fatal outcomes.

SourceAmerican Medical Association·JournalJournal of the American College of Cardiology·DateOct 14, 2004

Heart gene yields insights into evolution, disease risk

A study of 2,400 British middle-aged men found that the positive selection for a gene variant in the MMP3 gene resulted in a 43% lower incidence of coronary artery heart disease. The researchers suggest that this variation is not just harmless mutation, but rather a process contributing to population health.

SourceDuke University·JournalCurrent Biology·DateSep 6, 2004

Cincinnati Children's researchers identify link between heart disease and neurodegenerative diseases

Researchers at Cincinnati Children's Hospital Medical Center have discovered a link between heart disease and neurodegenerative diseases. The study found that toxic protein clusters called beta-amyloids, associated with Alzheimer's disease, are also present in the hearts of patients with heart failure.

SourceCincinnati Children's Hospital Medical Center·JournalProceedings of the National Academy of Sciences·DateJun 21, 2004

Chronic diseases need global health attention

Chronic diseases are the largest cause of death worldwide, with a projected increase in global prevalence over the next two decades. Key risk factors include tobacco use, unhealthful diets, and lack of physical activity, with most cases occurring in developing countries.

SourceJAMA Network·JournalJAMA·DateJun 1, 2004

OTC statins: A bad decision for public health

The UK government has rejected proposals to sell simvastatin over-the-counter for the primary prevention of heart disease due to financial reasons. This decision may increase inequalities as many people cannot afford the medication, which is currently prescribed to around 1.8 million people in the UK.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 20, 2004